MedTrace Logo

Vaccine Therapy in Treating Women With Metastatic Breast Cancer

NCT00003184 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL

Last updated 2013-04-04

No results posted yet for this study

Summary

RATIONALE: Vaccines made from breast cancer cells may make the body build an immune response to kill tumor cells.

PURPOSE: Phase I trial to study the effectiveness of vaccines made from breast cancer cells in treating women with metastatic breast cancer.

Conditions

Interventions

BIOLOGICAL

BCG vaccine

BIOLOGICAL

CD80 breast cancer vaccine

BIOLOGICAL

sargramostim

Sponsors & Collaborators

  • Providence Cancer Center, Earle A. Chiles Research Institute

    lead OTHER

Principal Investigators

  • Walter J. Urba, MD, PhD · Providence Cancer Center, Earle A. Chiles Research Institute

Study Design

Purpose
TREATMENT

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
1996-08-31
Completion
2003-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00003184 on ClinicalTrials.gov